# EDGAR Filing Document

**Accession Number:** 0000934549
**File Stem:** 0001683168-23-000104
**Filing Date:** 2023-1
**Character Count:** 15847
**Document Hash:** b9009adfbf004c816ed1d0f1cd1a003d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-23-000104.hdr.sgml**: 20230109

**ACCESSION NUMBER**: 0001683168-23-000104

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20230103

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230109

**DATE AS OF CHANGE**: 20230109

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ACACIA RESEARCH CORP
- **CENTRAL INDEX KEY:** 0000934549
- **STANDARD INDUSTRIAL CLASSIFICATION:** PATENT OWNERS & LESSORS [6794]
- **IRS NUMBER:** 954405754
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37721
- **FILM NUMBER:** 23516803

**BUSINESS ADDRESS:**
- **STREET 1:** 767 3RD AVENUE, 6TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 332-236-8500

**MAIL ADDRESS:**
- **STREET 1:** 767 3RD AVENUE, 6TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

?xml version="1.0" encoding="utf-8"?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d) OF**

**THE SECURITIES EXCHANGE ACT OF 1934**

Date of Report (Date of earliest event reported): **January 3, 2023**

**ACACIA RESEARCH CORPORATION**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-37721** | **95-4405754** |
| (State or other jurisdiction of | (Commission | (I.R.S. Employer |
| incorporation) | File Number) | Identification No.) |

---

---

| | |
|:---|:---|
| **767 Third Avenue, 6th Floor** |  |
| **New York, NY** | **10017** |
| (Address of principal executive offices) | (Zip Code) |

---

**(Registrant's telephone number, including area code): (332) 236-8500**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

□ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

□ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

□ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

□ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol** | **Name of each exchange on which registered** |
| Common Stock, par value $0.001 per share | ACTG | The NASDAQ Global Select Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). □ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

---

| | |
|:---|:---|
| **Item 5.02.** | **Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.** |

---

On January 3, 2023, Richard Rosenstein tendered his resignation as the Chief Financial Officer of Acacia Research Corporation, a Delaware corporation (the "<u>Company</u>"), effective as of January 27, 2023 (the "<u>Effective Date</u>"). The Company and Mr. Rosenstein intend to enter into a consulting agreement under which Mr. Rosenstein will agree to provide certain advisory services to the Company's Board of Directors (the "<u>Board</u>") and the Company's management team for a term beginning on the Effective Date and continuing through April 30, 2023, unless earlier terminated. In consideration of such services, Mr. Rosenstein will be entitled to receive fees in an aggregate amount equal to $10,000, payable in biweekly installments, and be entitled to reimbursement of reasonable business expenses incurred in the performance thereof, and the stock options, restricted stock, and other stock awards held by Mr. Rosenstein as of the Effective Time will continue to vest in accordance with their terms during the term of the consulting agreement, except as otherwise specified therein.

Effective January 28, 2023, Kirsten Hoover, the Company's Corporate Controller, will be appointed as interim Chief Financial Officer of the Company and will serve as the Company's principal financial officer and principal accounting officer, to hold such positions until her successor has been elected and qualified, or until her earlier death, resignation, or removal. The Board intends to commence a search for a permanent successor.

Information about Ms. Hoover's age, business experience and compensation has been previously reported, most recently in the Company's Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on April 29, 2022. In connection with Ms. Hoover's appointment as interim Chief Financial Officer, Ms. Hoover will receive an additional $15,000 per month in compensation during her tenure as interim Chief Financial Officer.

Ms. Hoover has no family relationships with any director or executive officer of the Company. There are no arrangements or understandings between Ms. Hoover and any other person pursuant to which Ms. Hoover was appointed as an executive officer. Additionally, there are no transactions involving Ms. Hoover that would require disclosure under Item 404(a) of Regulation S-K.

---

| | |
|:---|:---|
| **Item 7.01.** | **Regulation FD Disclosure.** |

---

On January 6, 2023, the Company issued a press release announcing the transition of Mr. Rosenstein and the appointment of Ms. Hoover as interim Chief Financial Officer, as described above. A copy of the press release is furnished as Exhibit 99.1.

As provided in General Instruction B.2 of Form 8-K, the information in Item 7.01 of this Current Report on Form 8-K (this "<u>Report</u>"), including Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "<u>Exchange Act</u>"), or otherwise subject to the liabilities of that section. Such information shall not be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as otherwise expressly set forth by specific reference in such filing.

**Cautionary Note Regarding Forward-Looking Statements.**

This Report contains "forward-looking statements" within the meaning of the federal securities laws, including, statements regarding the anticipated transitions of Mr. Rosenstein and Ms. Hoover, and the intention of the Company and Mr. Rosenstein to enter into a consulting agreement on the terms described in this Report. Forward-looking statements include all statements that are not solely historical facts and can be identified by terms such as "intend," "believe," "could," "estimate," "expect," "may," "should," or similar expressions. Investors are cautioned not to place undue reliance on these forward-looking statements, which are subject to numerous risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements, including the risks and uncertainties addressed under the heading "Risk Factors" and elsewhere in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2021, the Company's subsequent Quarterly Reports on Form 10-Q, and the other filings the Company makes with the U.S. Securities and Exchange Commission from time to time. These forward-looking statements speak only as of the date of this Report and the Company undertakes no obligation to update these forward-looking statements to reflect events or circumstances occurring after the date of this Report.

---

| | |
|:---|:---|
| **Item 9.01.** | **Financial Statements and Exhibits.** |

---

(d)&nbsp;&nbsp;&nbsp;&nbsp; *Exhibits*

---

| | |
|:---|:---|
| **Exhibit <br> No.** | **Description of Exhibit** |
| 99.1 | [Press Release , date January 9, 2023.](acacia_ex9901.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Dated: January 9, 2023 |  |  |
|  | ACACIA RESEARCH CORPORATION | ACACIA RESEARCH CORPORATION |
|  | By: | */s/ Jason W. Soncini* |
|  | Name: | Jason W. Soncini |
|  | Title: | General Counsel |

---

## Exhibit 99.1

**Exhibit 99.1**

Acacia Announces CFO Succession Plan

*<br> Richard Rosenstein Stepping Down to Pursue New Private Company Opportunity and Will Transition to*

*Consulting Role as of January 28*

 

*Kirsten Hoover, Acacia's Current Corporate Controller, to Become Interim CFO While the Board Conducts*

*CFO Search*

NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company") today announced that Richard Rosenstein, the Company's Chief Financial Officer, will step down from his position, effective at the close of business on January 27, 2023, to pursue another professional opportunity. Acacia thanks Mr. Rosenstein for his significant contributions and strong leadership during his tenure.

Gavin Molinelli, Chairman of the Board of Directors (the "Board"), commented:

"Rich has been a valued member of Acacia's leadership team since joining in June of 2020. In addition to helping us navigate the pandemic and monetize the acquisition of our life sciences portfolio, he has worked to streamline our capital structure and strengthen our financial base. Rich's efforts helped transform Acacia into a well-capitalized corporate acquisition platform and have positioned us to pursue attractive opportunities that can drive long-term shareholder value. We wish him the best as he pursues his next opportunity."

Mr. Rosenstein added:

"I've been presented with a unique opportunity that is aligned with my growth-investing roots. Fortunately, Acacia has developed a deep and experienced finance team to guide the Company forward. I appreciate the opportunity I've had to work with the Board, colleagues, such as Kirsten Hoover, and the Company's strategic partner Starboard Value, LP. Under MJ's leadership, I believe the organization is in great hands and possesses the right foundation for future success."

Acacia and Mr. Rosenstein intend to enter into a consulting agreement upon his departure as a full-time employee. The Company intends for Mr. Rosenstein to serve as a consultant through April 30, 2023. Effective as of January 28, 2023, Kirsten Hoover, who currently serves as Acacia's Corporate Controller and previously held other senior finance roles at the Company, will assume the role of interim Chief Financial Officer.

The Board has commenced a search for a new Chief Financial Officer. The process will be supported by a leading, independent executive search firm.

Mr. Rosenstein's departure is not the result of any dispute or disagreement with the Company, including with respect to matters related to the Company's accounting practices, general policies or financial reporting. Additional information pertaining to today's announcement will be included in a Current Report on Form 8-K to be filed by Acacia with the U.S. Securities and Exchange Commission (the "SEC").

<u>Kirsten Hoover Biography</u> 

Kirsten Hoover is an experienced corporate finance professional with strong institutional knowledge of Acacia and its go-forward strategy. She rejoined Acacia as its Corporate Controller in October 2021 after serving as the Senior Manager of Financial Reporting at Veritone Inc. (Nasdaq: VERI) from December 2019 through October 2021. Previously, Ms. Hoover held various accounting and finance roles at Acacia from 2002 through 2019, including as Corporate Controller from 2004 through 2019. She began her career in the Audit and Assurance practice within Deloitte, and holds a B.A. in Economics from the University of California, Santa Barbara.

**About the Company**

Acacia is a permanent capital platform with a strategy to purchase businesses based on the differentials between public and private market valuations. Acacia leverages its (i) access to flexible capital that can be deployed opportunistically as a result of its strategic partnership with Starboard Value, LP, (ii) disciplined focus on identifying opportunities where it can be an advantaged buyer, initiate a transaction opportunity spontaneously, avoid a traditional sale process and complete the purchase of a business, division or other asset at an attractive price, (iii) willingness to invest across industries and in off-the-run, often misunderstood assets that suffer from a complexity or multi-factor discount, (iv) relationships and partnership abilities across functions and sectors, and (v) strong expertise in corporate governance and operational transformation. Acacia seeks to identify opportunities where it believes it is an advantaged buyer, where it can avoid structured sale processes and create the opportunity to purchase businesses, divisions and/or assets of companies at an attractive price due to Acacia's unique capabilities, relationships or expertise, or Acacia believes the target would be worth more to it than to other buyers. Additional information about Acacia and its subsidiaries is available at www.acaciaresearch.com.

**Safe Harbor Statement**

This news release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, statements regarding the anticipated transitions of Mr. Rosenstein and Ms. Hoover, and the intention of the Company and Mr. Hoover to enter into a consulting agreement. Forward-looking statements include all statements that are not solely historical facts and can be identified by terms such as "intend," "believe," "could," "estimate," "expect," "may," "should," or similar expressions. Investors are cautioned not to place undue reliance on these forward-looking statements, which are subject to numerous risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements, including the risks and uncertainties addressed under the heading "Risk Factors" and elsewhere in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2021, the Company's subsequent Quarterly Reports on Form 10-Q, and the other filings the Company makes with the U.S. Securities and Exchange Commission from time to time. These forward-looking statements speak only as of the date of this news release and the Company undertakes no obligation to update these forward-looking statements to reflect events or circumstances occurring after the date of this news release.

**Contacts**

Investor Contact:

FNK IR

Rob Fink, 646-809-4048

rob@fnkir.com

Media Contact:

Longacre Square Partners

Greg Marose / Ashley Areopagita

ACTG@longacresquare.com